Article Information
History
- February 10, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Changchun Hou, BSc1,
- Xinxin Hao, MD, PhD2,
- Ning Sun, BSc1,
- Xiaolin Luo, MD, PhD1,
- Luyu Wang, BSc1,
- Enpu Yang, BSc1,
- Zhichun Gao, MD1,
- Ling Chen, BSc1,
- Zebi Wang, BSc1,
- Yun Cui, BSc1,
- Jing Zhong, BSc1,
- Juhao Yang, MD3,
- Xi Liu, MD1,* and
- Zhexue Qin, MD, PhD1,*
- 1Department of Cardiology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
- 2Clinical Research Center, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
- 3Department of Clinical Laboratory, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
- ↵*Address for correspondence:
Zhexue Qin MD, PhD, Department of Cardiology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China, Tel/fax +86 2368774001 Email:
zhexueqin{at}126.com, Xi Liu MD, Department of Cardiology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China, Tel/fax +86 2368774001 Email:
liuxi_tmmu{at}hotmail.com
Posted February 10, 2023.
Predicting hospital readmissions in patients receiving novel-dose Sacubitril/Valsartan therapy: A competing-risk, causal mediation analysis
